NDC Product
Human Prescription DrugMvasi NDC 55513-206
- Generic Name
- Bevacizumab-awwb
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Marketing
- BLA
Active Listing
BEVACIZUMAB
UNII 2S9ZZM9Q9V
Substance Identification & Data
This profile provides standardized clinical and technical data for Bevacizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2S9ZZM9Q9V.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 216974-75-3 and the RxNorm Concept ID (RxCUI) 253337. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
Preferred Name
BEVACIZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
2S9ZZM9Q9V
The specific atomic composition represented as a molecular structure string.
INN ID
8017
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
KK-78
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Bevacizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
FDA Official Name
BEVACIZUMAB
BEVACIZUMAB BETA
BEVACIZUMAB-ADCD
BEVACIZUMAB-AWWB
BEVACIZUMAB-BVZR
BEVACIZUMAB-MALY
BEVACIZUMAB-NWGD
BEVACIZUMAB-TNJN
Common Names & Synonyms
AVASTIN
BAT 1706 [WHO-DD]
BAT-1706 (BIOSIMILAR OF BEVACIZUMAB)
BEVACIZUMAB (AVASTIN)
BEVACIZUMAB [EMA EPAR]
BEVACIZUMAB [INN]
BEVACIZUMAB [JAN]
BEVACIZUMAB [MART.]
BEVACIZUMAB [MI]
BEVACIZUMAB [PURPLE BOOK CDER]
BEVACIZUMAB [USAN]
BEVACIZUMAB [VANDF]
BEVACIZUMAB [WHO-DD]
BEVACIZUMAB ADCD [WHO-DD]
BEVACIZUMAB AWWB [WHO-DD]
BEVACIZUMAB BETA [INN]
BEVACIZUMAB BETA [WHO-DD]
BEVACIZUMAB BIOSIMILAR - SHANGHAI HENLIUS BIOTECH
BEVACIZUMAB BIOSIMILAR (ABP-215)
BEVACIZUMAB BIOSIMILAR (AMGEN)
BEVACIZUMAB BIOSIMILAR (AMNEAL PHARMACEUTICALS)
BEVACIZUMAB BIOSIMILAR (CT-P16)
BEVACIZUMAB BIOSIMILAR (FKB-238)
BEVACIZUMAB BIOSIMILAR (GP-2019)
BEVACIZUMAB BIOSIMILAR (MABXIENCE)
BEVACIZUMAB BIOSIMILAR (PF-06439535)
BEVACIZUMAB BIOSIMILAR (PFIZER)
BEVACIZUMAB BIOSIMILAR-INNOVENT BIOLOGICS
BEVACIZUMAB BVZR [WHO-DD]
BEVACIZUMAB MALY [WHO-DD]
BEVACIZUMAB NWGD [WHO-DD]
BEVACIZUMAB TNJN [WHO-DD]
BEVACIZUMAB, LICENSE HOLDER UNSPECIFIED
BEVACIZUMAB-AWWB [PURPLE BOOK CDER]
BI 695502 [WHO-DD]
BS-503
FKB 238 [WHO-DD]
HLX 04 [WHO-DD]
HLX04-O (RECOMBINANT ANTI-VEGF HUMANIZED MONOCLONAL ANTIBODY OPHTHALMIC INJECTION)
IBI 305 [WHO-DD]
IBI305
IBI-305
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL RHUMAB-VEGF .GAMMA.-CHAIN ANTI-HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL RHUMAB-VEGF LIGHT CHAIN, DIMER
LY 01008 [WHO-DD]
LY 01008(BIOSIMILAR OF BEVACIZUMAB)
PF-06439535 [WHO-DD]
QL-1101 (BIOSIMILAR OF BEVACIZUMAB)
USP MAB 002, MONOCLONAL IGG1 [USP-RS]
Brand / Trade Names
ALYMSYS
AVZIVI
BEVAX
BYVASDA
JOBEVNE
MVASI
OYAVAS
VEGZELMA
ZIRABEV
Technical Codes
12-IGG1
ABP-215
AVA-1
BAT1706
BAT-1706
BEVZ92
BEVZ-92
BI695502
BI-695502
BS-503A
CT16
CT-16
CTP16
CTP-16
CT-P16
CT-P16 (BIOSIMILAR OF BEVACIZUMAB)
FKB238
FKB-238
GP2019
GP-2019
HLX04
HLX-04
HLX04-O
LY 01008
LY-01008
MB02
MB-02
PF-06439535
Q1101
Q-1101
RG-435
RHUMAB-
RO-4876646
NDC Products Containing BEVACIZUMAB
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:
